A new study found methylphenidate to be effective in treating apathy in individuals with Alzheimer disease. At a time when the recent aducanumab approval is focusing attention on the promise of disease-modifying therapies, the new findings highlight the importance of developing better symptomatic treatment options for individuals with psychiatric disorders of Alzheimer disease.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011363 | PMC |
| http://dx.doi.org/10.1038/s41582-021-00591-9 | DOI Listing |
Publication Analysis
Top Keywords
alzheimer disease
12
disease
4
disease modification
4
modification symptomatic
4
symptomatic therapies
4
therapies alzheimer
4
disease study
4
study methylphenidate
4
methylphenidate effective
4
effective treating
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!